166 related articles for article (PubMed ID: 30204052)
1. Homology modeling of human histone deacetylase 10 and design of potential selective inhibitors.
Ibrahim Uba A; Yelekçi K
J Biomol Struct Dyn; 2019 Sep; 37(14):3627-3636. PubMed ID: 30204052
[TBL] [Abstract][Full Text] [Related]
2. Crystallographic structure versus homology model: a case study of molecular dynamics simulation of human and zebrafish histone deacetylase 10.
Uba AI; Yelekçi K
J Biomol Struct Dyn; 2020 Sep; 38(15):4397-4406. PubMed ID: 31701819
[TBL] [Abstract][Full Text] [Related]
3. Identification of potential isoform-selective histone deacetylase inhibitors for cancer therapy: a combined approach of structure-based virtual screening, ADMET prediction and molecular dynamics simulation assay.
Uba AI; Yelekçi K
J Biomol Struct Dyn; 2018 Sep; 36(12):3231-3245. PubMed ID: 28938863
[TBL] [Abstract][Full Text] [Related]
4. Selective Inhibition of Histone Deacetylase 10: Hydrogen Bonding to the Gatekeeper Residue is Implicated.
Géraldy M; Morgen M; Sehr P; Steimbach RR; Moi D; Ridinger J; Oehme I; Witt O; Malz M; Nogueira MS; Koch O; Gunkel N; Miller AK
J Med Chem; 2019 May; 62(9):4426-4443. PubMed ID: 30964290
[TBL] [Abstract][Full Text] [Related]
5. Exploring structural requirements of HDAC10 inhibitors through comparative machine learning approaches.
Bhattacharya A; Amin SA; Kumar P; Jha T; Gayen S
J Mol Graph Model; 2023 Sep; 123():108510. PubMed ID: 37216830
[TBL] [Abstract][Full Text] [Related]
6. Homology modeling and
Elmezayen AD; Yelekçi K
J Biomol Struct Dyn; 2021 Oct; 39(17):6396-6414. PubMed ID: 32715940
[TBL] [Abstract][Full Text] [Related]
7. Carboxylic acid derivatives display potential selectivity for human histone deacetylase 6: Structure-based virtual screening, molecular docking and dynamics simulation studies.
Uba AI; Yelekçi K
Comput Biol Chem; 2018 Aug; 75():131-142. PubMed ID: 29859380
[TBL] [Abstract][Full Text] [Related]
8. Insights into structural features of HDAC1 and its selectivity inhibition elucidated by Molecular dynamic simulation and Molecular Docking.
Sixto-López Y; Bello M; Correa-Basurto J
J Biomol Struct Dyn; 2019 Feb; 37(3):584-610. PubMed ID: 29447615
[TBL] [Abstract][Full Text] [Related]
9. A Computational Approach to Investigate the HDAC6 and HDAC10 Binding Propensity of Psidium guajava-derived Compounds as Potential Anticancer Agents.
Adewole KE; Ishola AA
Curr Drug Discov Technol; 2021; 18(3):423-436. PubMed ID: 32357815
[TBL] [Abstract][Full Text] [Related]
10. An insight into selective and potent inhibition of histone deacetylase 8 through induced-fit docking, pharmacophore modeling and QSAR studies.
Kashyap K; Kakkar R
J Biomol Struct Dyn; 2020 Jan; 38(1):48-65. PubMed ID: 30633630
[TBL] [Abstract][Full Text] [Related]
11. Toward selective histone deacetylase inhibitor design: homology modeling, docking studies, and molecular dynamics simulations of human class I histone deacetylases.
Wang DF; Helquist P; Wiech NL; Wiest O
J Med Chem; 2005 Nov; 48(22):6936-47. PubMed ID: 16250652
[TBL] [Abstract][Full Text] [Related]
12. Structural Basis for the Selective Inhibition of HDAC10, the Cytosolic Polyamine Deacetylase.
Herbst-Gervasoni CJ; Steimbach RR; Morgen M; Miller AK; Christianson DW
ACS Chem Biol; 2020 Aug; 15(8):2154-2163. PubMed ID: 32659072
[TBL] [Abstract][Full Text] [Related]
13. Identification of histone deacetylase 10 (HDAC10) inhibitors that modulate autophagy in transformed cells.
Zeyen P; Zeyn Y; Herp D; Mahmoudi F; Yesiloglu TZ; Erdmann F; Schmidt M; Robaa D; Romier C; Ridinger J; Herbst-Gervasoni CJ; Christianson DW; Oehme I; Jung M; Krämer OH; Sippl W
Eur J Med Chem; 2022 Apr; 234():114272. PubMed ID: 35306288
[TBL] [Abstract][Full Text] [Related]
14. Screening of novel histone deacetylase 7 inhibitors through molecular docking followed by a combination of molecular dynamics simulations and ligand-based approach.
Yuan Y; Hu Z; Bao M; Sun R; Long X; Long L; Li J; Wu C; Bao J
J Biomol Struct Dyn; 2019 Sep; 37(15):4092-4103. PubMed ID: 30417746
[TBL] [Abstract][Full Text] [Related]
15. Homology modeling of parasite histone deacetylases to guide the structure-based design of selective inhibitors.
Melesina J; Robaa D; Pierce RJ; Romier C; Sippl W
J Mol Graph Model; 2015 Nov; 62():342-361. PubMed ID: 26595183
[TBL] [Abstract][Full Text] [Related]
16. Hydroxamic acid derivatives as selective HDAC3 inhibitors: computer-aided drug design strategies.
Patel P; Shrivastava SK; Sharma P; Kurmi BD; Shirbhate E; Rajak H
J Biomol Struct Dyn; 2024; 42(1):362-383. PubMed ID: 36995068
[TBL] [Abstract][Full Text] [Related]
17. Diarylcyclopropane hydroxamic acid inhibitors of histone deacetylase 4 designed by combinatorial approach and QM/MM calculations.
Kollar J; Frecer V
J Mol Graph Model; 2018 Oct; 85():97-110. PubMed ID: 30145395
[TBL] [Abstract][Full Text] [Related]
18. Molecular modeling study on tunnel behavior in different histone deacetylase isoforms.
Thangapandian S; John S; Lee Y; Arulalapperumal V; Lee KW
PLoS One; 2012; 7(11):e49327. PubMed ID: 23209570
[TBL] [Abstract][Full Text] [Related]
19. First Fluorescent Acetylspermidine Deacetylation Assay for HDAC10 Identifies Selective Inhibitors with Cellular Target Engagement.
Herp D; Ridinger J; Robaa D; Shinsky SA; Schmidtkunz K; Yesiloglu TZ; Bayer T; Steimbach RR; Herbst-Gervasoni CJ; Merz A; Romier C; Sehr P; Gunkel N; Miller AK; Christianson DW; Oehme I; Sippl W; Jung M
Chembiochem; 2022 Jul; 23(14):e202200180. PubMed ID: 35608330
[TBL] [Abstract][Full Text] [Related]
20. Molecular cloning and characterization of a novel histone deacetylase HDAC10.
Guardiola AR; Yao TP
J Biol Chem; 2002 Feb; 277(5):3350-6. PubMed ID: 11726666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]